Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cell and Gene Therapy Catapult (CGT Catapult) is a center of excellence based in the United Kingdom, established to bridge the gap between scientific research and full-scale commercialization of advanced therapies. Its flagship Manufacturing Centre in Stevenage operates a unique collaborative model, providing biotech companies with dedicated GMP-compliant cleanroom suites and support services to manufacture their own products. The organization offers expertise in process development, regulatory affairs, and supply chain logistics to accelerate the delivery of cell and gene therapies to patients. By reducing the risk and cost of infrastructure investment, the CGT Catapult enables developers to scale up production for clinical trials and global markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gene Therapy Catapult Manufacturing Centre.